Drug Shortage Report for NAT-ERLOTINIB

Last updated on 2024-02-02 History
Report ID 129550
Drug Identification Number 02483920
Brand name NAT-ERLOTINIB
Common or Proper name Erlotinib Hydrochloride
Company Name NATCO PHARMA (CANADA) INC
Market Status MARKETED
Active Ingredient(s) ERLOTINIB
Strength(s) 100MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size bottle of 30s
ATC code L01XE
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2020-12-01
Actual start date 2020-12-01
Estimated end date 2025-06-30
Actual end date
Shortage status Actual shortage
Updated date 2024-02-02
Company comments Long term back order
Health Canada comments
Tier 3 Status No
Contact Address 2000 ARGENTIA ROAD, PLAZA 1, SUITE 200
MISSISSAUGA, ONTARIO
CANADA L5N 1P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2024-02-02 French Compare
v9 2024-02-02 English Compare
v8 2024-02-02 English Compare
v7 2023-05-17 English Compare
v6 2023-05-03 French Compare
v5 2023-05-03 English Compare
v4 2022-01-17 French Compare
v3 2022-01-17 English Compare
v2 2020-12-03 French Compare
v1 2020-12-03 English Compare

Showing 1 to 10 of 10